Scientific
Programs.
GC Biopharma USA is committed to supporting ethical, independent research that advances scientific and medical understanding within our key therapeutic areas.
Investigator-Initiated Research
GC Biopharma USA is committed to supporting ethical, independent research that advances scientific and medical understanding within our key therapeutic areas. The Investigator-Initiated Research (IIR) program supports U.S. investigators and institutions in pursuing original research concepts that may generate meaningful insights for patients, healthcare providers, and the broader scientific community.
All concepts and full proposals are reviewed by GC Biopharma USA's internal scientific and medical review committee on a rolling basis. Review criteria include, but are not limited to, alignment with strategic priorities, scientific merit, clinical relevance, and feasibility.
We are currently accepting proposals in these areas:
- Immunodeficiencies (primary and secondary)
- Immunoglobulin therapies
Questions?
Contact our medical affairs team at medicalinfo@gcbiopharmausa.com.
Funding or support of an IIR study does not imply endorsement of study outcomes or conclusions.
